Copernicus Therapeutics

Copernicus Therapeutics

Pharmaceuticals, Cedar Ave Ste 145, Cleveland, , 44106, Ohio, 11000, United States, 1-10 Employees

cgsys.com

  • LinkedIn

phone no Phone Number: 12*********

Who is COPERNICUS THERAPEUTICS

Copernicus Therapeutics, Inc. (CTI) is a clinical stage genomics medicines company whose technology can potentially enable patients with certain genetic disorders to achieve a truly funct...

Read More

map
  • 11000 Cedar Ave Ste 145, Cleveland, Ohio, 44106, United States Headquarters: 11000 Cedar Ave Ste 145, Cleveland, Ohio, 44106, United States
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $5 Million to $10 Million

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 8731

checked-icon Does something look wrong? Fix it. | View contact records from COPERNICUS THERAPEUTICS

Copernicus Therapeutics Org Chart and Mapping

Employees

Jan Candelaria

Manager, Administration

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Copernicus Therapeutics

Answer: Copernicus Therapeutics's headquarters are located at Cedar Ave Ste 145, Cleveland, , 44106, Ohio, 11000, United States

Answer: Copernicus Therapeutics's phone number is 12*********

Answer: Copernicus Therapeutics's official website is https://cgsys.com

Answer: Copernicus Therapeutics's revenue is $5 Million to $10 Million

Answer: Copernicus Therapeutics's SIC: 8731

Answer: Copernicus Therapeutics has 1-10 employees

Answer: Copernicus Therapeutics is in Pharmaceuticals

Answer: Copernicus Therapeutics contact info: Phone number: 12********* Website: https://cgsys.com

Answer: Copernicus Therapeutics, Inc. (CTI) is a clinical stage genomics medicines company whose technology can potentially enable patients with certain genetic disorders to achieve a truly functional cure. Our proprietary, non-viral, nucleic acid delivery platform can carry large payloads and achieves a robust gene transfer through a receptor-mediated mechanism, without inducing the immune response that limits treatment with AAV. Combined with world-class intellectual property in plasmid design for long-term and controlled expression, CTI is poised to become a leader in the 21st century in genomic and precision medicine. Current programs include: Cystic Fibrosis (Phase I/II Complete) Eye (Pre-clinical) Brain (Pre-clinical) Founded on technologies developed at Case Western Reserve University in Cleveland, Ohio, CTI has a strong connection to the growing biotechnology industry in Northeast Ohio.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access